CAS 1401031-52-4

N-(1-Methylethyl)-5-[2-(4-pyridinyl)ethynyl]-2-pyridinecarboxamide

Description:

N-(1-Methylethyl)-5-[2-(4-pyridinyl)ethynyl]-2-pyridinecarboxamide, identified by its CAS number 1401031-52-4, is a chemical compound characterized by its complex structure, which includes a pyridine ring and an ethynyl group. This compound features a carboxamide functional group, contributing to its potential as a bioactive molecule. The presence of the 4-pyridinyl substituent suggests possible interactions with biological targets, making it of interest in medicinal chemistry. Its molecular structure indicates that it may exhibit lipophilic properties due to the alkyl and aromatic components, which can influence its solubility and permeability in biological systems. Additionally, the ethynyl group may impart unique reactivity, allowing for further chemical modifications. Overall, this compound's characteristics suggest potential applications in pharmaceutical development, particularly in the design of targeted therapies or as a lead compound in drug discovery. However, specific biological activity and safety profiles would require further investigation through experimental studies.

Formula: C₁₆H₁₅N₃O

InChI: InChI=1S/C16H15N3O/c1-12(2)19-16(20)15-6-5-14(11-18-15)4-3-13-7-9-17-10-8-13/h5-12H,1-2H3,(H,19,20)

InChI key: InChIKey=STAFRSGTRKNXHF-UHFFFAOYSA-N

SMILES: C(NC(C)C)(=O)C1=CC=C(C#CC=2C=CN=CC2)C=N1

Synonyms:

• 2-Pyridinecarboxamide, N-(1-methylethyl)-5-[2-(4-pyridinyl)ethynyl]-
• LSN 2463359
• N-(1-Methylethyl)-5-[2-(4-pyridinyl)ethynyl]-2-pyridinecarboxamide

2-Pyridinecarboxamide, N-(1-methylethyl)-5-[2-(4-pyridinyl)ethynyl]-

CAS: 1401031-52-4

Formula: C₁₆H₁₅N₃O

Purity: 98%

Color and Shape: Solid

Molecular weight: 265.3098

Ref: IN-DA001C19

LSN2463359

CAS: 1401031-52-4

LSN2463359

Purity: ≥98%

Molecular weight: 265.31g/mol

Ref: 54-BUP13057

LSN 2463359

CAS: 1401031-52-4

LSN 2463359 is a novel, potent, and selective allosteric modulator of the metabotropic glutamate receptor. It is currently in clinical development for the treatment of neurodevelopmental disorders such as attention deficit hyperactivity disorder (ADHD) and narcolepsy. LSN 2463359 has been shown to be safe and well tolerated in vivo studies in rats and mice. The drug improved ADHD-related symptoms in rodent models of ADHD. LSN 2463359 also reduced cataplexy episodes in narcoleptic patients who had been unresponsive to other treatments.

Formula: C₁₆H₁₅N₃O

Purity: Min. 95%

Molecular weight: 265.31 g/mol

Ref: 3D-BGC03152

LSN2463359

CAS: 1401031-52-4

LSN2463359 is a positive allosteric modulators of the mGlu5 receptor.

Formula: C₁₆H₁₅N₃O

Purity: 99.26%

Color and Shape: Solid

Molecular weight: 265.31

Ref: TM-T27854